- 1 A Patient With Pneumocystis Jiroveci Is Receiving Intravenous Sulfamethoxazole Trimethoprim Bactrim The Medication 1 (44.08 KiB) Viewed 31 times
1. A patient with pneumocystis jiroveci is receiving intravenous Sulfamethoxazole/Trimethoprim (Bactrim). The medication
-
answerhappygod
- Site Admin
- Posts: 899603
- Joined: Mon Aug 02, 2021 8:13 am
1. A patient with pneumocystis jiroveci is receiving intravenous Sulfamethoxazole/Trimethoprim (Bactrim). The medication
1. A patient with pneumocystis jiroveci is receiving intravenous Sulfamethoxazole/Trimethoprim (Bactrim). The medications are mixed in 500ml of 5% Dextrose in Water to infuse over 90 minutes. What is the rationale for using this amount of IV fluid? A. To prevent hypotension. B. To maintain hydration. C. To maintain fluid and electrolyte balance. D. To prevent crystalluria.